Haleon plc Updates on Share Purchase with Pfizer
Ticker: HLNCF · Form: 6-K · Filed: Mar 19, 2025 · CIK: 1900304
| Field | Detail |
|---|---|
| Company | Haleon PLC (HLNCF) |
| Form Type | 6-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-purchase, transaction-update, company-announcement
Related Tickers: PFE
TL;DR
Haleon & Pfizer did a share deal, details in the 3/19/25 update.
AI Summary
Haleon plc announced on March 19, 2025, an update regarding an off-market purchase of shares conducted alongside Pfizer. The filing references a press release dated March 19, 2025, titled 'Update on off-market purchase alongside Pfizer'.
Why It Matters
This filing provides transparency on significant share transactions involving Haleon and its former parent company, Pfizer, which can impact investor perception and stock valuation.
Risk Assessment
Risk Level: low — The filing is an informational update on a past transaction and does not introduce new financial risks.
Key Players & Entities
- Haleon plc (company) — Registrant
- Pfizer (company) — Partner in share purchase
- March 19, 2025 (date) — Date of announcement and press release
FAQ
What type of transaction is being updated in the filing?
The filing is an update on an off-market purchase of shares conducted alongside Pfizer.
What is the date of the press release referenced in the filing?
The press release referenced is dated March 19, 2025.
What is the title of the press release included as an exhibit?
The title of the press release is 'Update on off-market purchase alongside Pfizer'.
What is the Commission File Number for Haleon plc?
The Commission File Number for Haleon plc is 001-41411.
Does Haleon plc file annual reports under Form 20-F or Form 40-F?
Haleon plc files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 19, 2025 regarding Haleon plc (HLNCF).